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ABSTRACT
Objective: The objective of the present work was to develop and evaluate a matrix system for chronotherapeutic delivery of diclofenac sodium using 
almond gum as a carrier for the treatment rheumatoid arthritis.
Methods: Matrix tablets of diclofenac sodium were prepared using 30, 40, 50, 60, and 70% w/w of tablet using almond gum as a carrier by wet 
granulation technique. These tablets were compression coated with Eudragit S100 to prevent drug release in the stomach. All formulations were 
evaluated for hardness, friability, weight variation, drug content, in vitro and in vivo studies. The release kinetics were studied. The almond gum 
was characterized by viscosity measurements and Fourier transform infrared spectroscopy (FTIR) analysis. The coated (FC1 to FC5) and uncoated 
tablets (F1 to F5) were evaluated for in vitro release of diclofenac sodium after sequential exposure to pH 1.2, pH 7.4, and pH 6.8, respectively, for 2 hr, 
3 hr, and 19 hr in the absence as well as presence of rat cecal content. The selected formulation was subjected to in vivo targeting efficacy studies by 
roentgenography technique.
Results: In vitro release studies indicated that the matrix tablets (F1 to F5) failed to control the drug release in the physiological environment of the 
stomach and small intestine. On the other hand, compression-coated formulations were able to protect the tablet cores from premature drug release. 
In the presence of rat cecal contents, FC5 formulation has shown highest release for longer period when compared to that of FC5 in the absence of 
cecal contents. The values of the correlation coefficient indicated that the drug release followed zero order drug release kinetics with Peppas drug 
release mechanism. FTIR studies confirmed that there was no interaction between the drug and the carrier. X-ray studies confirmed that the tablet 
successfully reached colon without getting disintegrated in upper gastrointestinal tract.
Conclusion: Based on the results, selective delivery of diclofenac sodium to the colon could be achieved using 70% w/w (FC5) of almond gum matrix 
tablets compression coated with Eudragit S100 as a carrier.
Keywords: Diclofenac sodium, Gum almond, Eudragit S100, Roentgenography, Rat cecal content.
INTRODUCTION
The site specificity of drugs to the colonic part is advantageous for 
the localized and systemic treatments of various diseases conditions. 
Colon targeting was attained a significant role in the treatment of local 
pathologies and chronotherapy of various disorders includes asthma, 
rheumatoid arthritis (RA), and hypertension [1].
RA is an autoimmune disease. The patient suffers from severe pain in 
early morning hours due to release of inflammatory cell mediators such 
as interleukin-6, cortisol, and melatonin. Diclofenac is drug of choice for 
treatment of RA [2]. Present work has been aimed for the development 
of site-specific drug delivery systems of diclofenac for colon region 
in the form of oral tablet dosage form. When the formulation was 
administered at night time, the symptoms that are experienced during 
early morning hours can be treated. The system is based on lag time 
in drug release. Conventional formulation fails to produce the desired 
drug release due to rapid absorption [3].
Various natural gums have employed as rate controlling polymers. In 
recent years, gums are found in the literature because they are cheap 
and easily available [2]. In this work, it explores the feasibility of natural 
almond gum for colon-specific drug delivery. Almond gum is a natural 
polysaccharide obtained from stems and branches of Amygdalus communis 
belonging to the family rosaceae [4]. The monosaccharide of almond gum 
contains glucose, xylose, galactose, arabinose, and little rhamnose and 
fructose and their molar ratios of monosaccharide were 24.35:9.25:33.75
:31.60:0.74:0.31. The main chain of polysaccharide of almond gum could 
contain 1, 6-linked galactose and 1, 4-linked arafinose [5].
The aim of this study was to explore the feasibility of the natural 
 gum-dependent chronotherapeutic drug delivery system (CDDS), 
diclofenac sodium being selected as a model drug.
METHODS
Materials
Diclofenac sodium and potassium dihydrogen orthophosphate were 
purchased from Qualigens Fine Chemicals, Mumbai, India. Almond gum 
was obtained from the bark of the Prunus Communis tree. Magnesium 
Stearate is a gift sample from S.D Fine Chemicals Pvt., Ltd., Mumbai, 
India. All reagents and chemicals were of analytical grade and used as 
received.
Drug and excipient compatibility studies
Fourier transform infrared spectroscopy (FTIR)
IR spectra were recorded between 400 and 4000/cm by a Perkin Elmer 
1600 Series FTIR (Norwalk, USA). Each sample was mixed with KBr 
(FTIR Grade, Aldrich, Steinhelm, Germany) and compressed at 70 kN 
with a Perkin-Elmer hydraulic press.
Determination of viscosity and swelling index of the polymer
Viscosity and swelling index of almond gum were measured in water, 
0.1 N HCL, pH 7.4 phosphate buffer, and pH 6.8 phosphate buffer. 
Viscosity in these buffers was measured using Brookfield viscometer 
using spindle number SC 4-18. 1 g of gum was added to 10 ml of 
distilled water.
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The measuring cylinder was shaken vigorously for 10 minutes and 
allowed to stand for 24 hrs. Swelling capacity was expressed as:
Swelling capacity (%v/v)= (XV/XI)*100
Where Xv is the final volume occupied by swollen material after 24 hrs 
and XI denotes the initial volume of the powder in graduated measuring 
cylinder. The results were tabulated.
Physical properties of pure drug and carrier [6]
Various physical properties such as bulk density, compressibility index, 
Hausner’s ratio, and angle of repose [7] were determined for pure drug 
and carrier. Angle of repose was determined by fixed funnel method by 
placing ten grams of powder blend in a plugged glass funnel and was 
then allowed to flow through the funnel orifice by removing the cotton 
plug from the funnel orifice. The height of the heap (h) formed as well 
as the radius of the heap (r) was noted. The angle of repose (α) was 
calculated as: Tan α = (h/r). Bd and Td of 10 g of powder blend were 
determined using 50 ml graduated cylinder. The volume occupied by 
the granules was read, and the (Bd) calculated in g/ml. The cylinder 
containing the granules was tapped until constant volume was obtained 
using Bd apparatus from a height of 2 cm, and the Td calculated in g/ml. 
The percentage compressibility (CI) was calculated from the difference 
between the Td and the Bd divided by the Td and the ratio expressed as 
a percentage. The HR is the ratio between the Td and Bd [7].
Preparation of core tablets
Accurately weighed quantities of the drug, polymer (almond gum) 
lactose and binder (PVP-K 30) were physically mixed with a mortar and 
pestle. Required quantity of solvent (Isopropyl alcohol) was added and 
was mixed thoroughly to form a damp mass suitable for the preparation 
of granules. The dough mass was passed through sieve # no 10 to 
form granules which were dried in an oven at 50°C. Finally, talc and 
magnesium stearate were added to granules before punching the tablet. 
These granules were subjected to evaluate various flow properties. Now, 
the granules were compressed to form tablets in a Rotary punch tablet 
machine using 9 mm round concave punches at an optimum pressure. 
Ten formulations were prepared by varying the amount of gum almond, 
30, 40, 50, 60, and 70% w/w of the tablet and coded as F1, F2, F3, F4 
and F5 and FC1, FC2, FC3, FC4 and FC5, respectively. The composition 
of different formulations was shown in the Table 1.
Compression coating of core tablets using Eudragit S 100
The prepared tablets were compression coated with Eudragit S 100 
in order to retard the drug release in the stomach. Each core tablet is 
coated with 200 mg of Eudragit S 100 granules (made with IPA). Initially, 
half of the coating material (100 mg) was placed in the 11 mm die cavity 
upon which the core tablet is kept and the remaining half of the coating 
material (100 mg) was placed on it. Then the contents are compressed 
under optimum pressure to form coating on the core tablets.
In-process quality control (IPQC) parameters for tablets [8]
The formulated tablets were evaluated for different IPQC parameters 
such as drug content, weight variation, hardness, and friability. The 
results were tabulated.
In vitro drug release studies
Dissolution studies were carried out using USPXXII, Paddle method 
(apparatus II). The stirring speed was maintained at 100 rpm. The 
tablets were placed in simulated gastric fluid (SGF - pH 1.2) for 2 hrs, 
simulated intestinal fluid (SIF pH 7.4) for 3 hrs the average small 
intestine transit time is about 3 hrs. Then the dissolution medium was 
replaced with simulated colonic fluid (SCF pH 6.8) and the study was 
continued for a period of 19 hr. Sampling was done at predetermined 
time intervals, and the samples of 5 ml were collected and estimated for 
drug content after suitable dilution by UV method.
In vitro drug release testing in the presence of rat cecal content 
medium [9]
The experimental protocol was subjected to the scrutiny of the 
Institutional Animal Ethical Committee (IAEC/VIII/8/BCOP/2014) 
and was approved before commencement of the experimentation on 
animals.
In vitro drug release, studies were investigated in the presence of rat 
cecal content after 5 hrs of dissolution (first 2 hrs in 0.1 N HCl and 
another 3 hrs in pH 7.4 phosphate buffer). The albino rats weighing 
between 150 and 200 g were kept on normal diet and administered 
the 2.5 ml of 1% w/v solution of almond gum in water with the help 
of Teflon tubing directly into the esophagus region via oral cavity. The 
treatment was continued for 7 days to induce enzyme responsible for 
gum degradation, animals were sacrificed before 30 min of commencing 
drug release studies and the cecum was exteriorized for content 
collection. The cecal content (anaerobic) were immediately transferred 
into buffer saline solution pH 6.8 to obtain the appropriate 4% w/v 
concentration solution which was bubbled with carbon dioxide gas to 
maintain an anaerobic environment. Using USP dissolution rate testing 
apparatus Paddle type (100 rpm, 37±0.5°C) in anaerobic conditions 
with modifications the procedure was done. A beaker containing 250 ml 
of 4% w/v rat cecal content medium was immersed in dissolution bowl 
and the bowl volume was adjusted to 900 ml with phosphate buffer 
pH 6.8, which was kept in the water bath of the apparatus. The best 
formulation was placed in the Paddle of the apparatus and immersed 
in the rat cecal content medium. As the cecum is naturally anaerobic, 
the experiment was carried out with continuous CO2 supply into the 
beakers. At different time intervals, 5 ml of the samples was withdrawn 
without a pre-filter and replaced with 5 ml of fresh phosphate buffered 
saline bubbled with CO2 and the experiment was continued for 19 hr as 
the usual colonic transit time is 20-30 hr.
Drug release mechanism and kinetics [10]
The dissolution data were fitted to popular release models such as zero-
order, first-order, Higuchi and Peppa’s-Korsemeyer equation models. 
The order of drug release from matrix systems was described by using 
zero order kinetics or first orders kinetics. The mechanism of drug 
release from the matrix systems was studied using Higuchi equation 
and Peppa’s-Korsemeyer equation.
Drug dissolution from dosage forms that do not disaggregate and 
release the drug slowly can be represented by the zero order release 
kinetics equation: Qt = Q0+ K0t; Where Qt is the amount of drug 
dissolved in time t, Q0 is the initial amount of drug in the solution (most 
times, Q0 = 0) and K0 is the zero order release constant expressed 
Table 1: Composition of diclofenac sodium matrix tablets
Serial number Ingredients F1 F2 F3 F4 F5 FC1 FC2 FC3 FC4 FC5
1 Diclofenac sodium (mg) 100 100 100 100 100 100 100 100 100 100
2 Almond gum (mg) 150 200 250 300 350 150 200 250 300 350
3 PVP K30 (mg) 25 25 25 25 25 25 25 25 25 25
4 Lactose (mg) 215 165 115 65 15 215 165 115 65 15
5 Mg. stearate (mg) 5 5 5 5 5 5 5 5 5 5
6 Talc (mg) 5 5 5 5 5 5 5 5 5 5
7 Eudragit S100 (mg) - - - - - 200 200 200 200 200
8 Total (mg) 500 500 500 500 500 700 700 700 700 700
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in units of concentration/time. The release of the drug, which followed 
first order kinetics, can be expressed by the first order release kinetic 
equation: Log C = log C0−Kt/2.303; where C0 is the initial concentration 
of drug, K is the first-order rate constant and t is the time. Higuchi 
equation defines a linear dependence of the active fraction released per 
unit of surface (Q) on the square root of time and can be expressed as 
Q = KH t
1/2; Where, KH is the release rate constant. This equation describes 
drug release as a diffusion process based on the Fick’s law, square root 
time dependent. In order to define a model, this would represent a 
better fit for the formulation, dissolution data was further analyzed 
by Peppas and Korsmeyer equation. Mt/M∞ = K tn; Where Mt/M∞ is a 
fraction of drug released at time t, K is the release rate constant and n 
is the release exponent. In this model, the value of n characterizes the 
release mechanism of drug. For the case of cylindrical tablets, n=0.45 
corresponds to a Fickian diffusion mechanism, 0.45<n<0.89 to non-
Fickian transport, n=0.89 to Case II (relaxation) transport, and n>0.89 
to super Case II transport.
In vivo targeting efficacy [11,12]
In vivo targeting efficiency study was carried out to check the 
efficiency of the formulation to target to colon after obtaining ethical 
clearance (IAEC/VIII/8/BCOP/2014). The evaluation of dosage form 
in animal model renders support to the in vitro studies. To closely 
simulate the human physiological environment of the colon, rabbits 
were selected as an animal model for evaluating the colon-specific 
delivery. Roentgenography study [12] a comparatively safer technique 
was carried out in healthy male albino rabbits to access the in vivo 
performance of the selected batch. The behavior of diclofenac sodium 
tablets in rabbit was observed using a radiographic imaging technique. 
It involves the use of radio-opaque marker like barium sulfate, 
incorporated in the formulation to determine the position of the tablet. 
Healthy rabbit of 1.58 kg was fasted overnight and on the next day 
morning tablet was administered followed by giving 25 ml of water. At 
different time intervals of 2 hrs, 5 hrs, 8 hrs, 17 hrs, and 20 hrs, X-ray 
images were taken under the supervision of a radiologist, to follow the 
nature, movement, location, and the integrity of the tablets in different 
parts of gastrointestinal tract (GIT).
RESULTS AND DISCUSSION
The present study was aimed at developing oral colon targeted 
formulations for diclofenac sodium using natural polymer, almond 
gum in various concentrations. Among the various approaches of colon 
targeting, bacterial degradation of the polymer in the region of the colon 
is an easy approach. For this purpose, matrix tablets of the diclofenac 
were prepared with almond gum employing various concentrations.
FTIR analysis
The characteristic IR absorption peaks of diclofenac sodium were:
The FTIR spectra of the pure drug and formulations of almond gum 
indicated that no chemical interaction occurred between the drug, 
diclofenac sodium, and the carriers.
Physical properties of carrier and drug
Flow properties of the pure drug alone were poor when compared 
with the formulated granules. This may be due to the attractive forces 
between the molecules of the pure drug which are not allowing the 
particles to flow easily. Hence, in order to improve the flow properties, 
wet granulation technique is employed.
Evaluation parameters
Physicochemical characteristics of tablets
The hardness of the tablets was found to be 7 kg/cm2. Weight variation, 
Friability, and drug content were within the pharmacopoeia limits.
Viscosity and swelling indexes
Viscosity and swelling index were observed for almond gum in water, 
0.1 N HCl, pH 7.4 phosphate buffer and pH 6.8 phosphate buffer. 
Viscosities of almond gum were found to be high. The highest viscosity 
was found in 7.4 phosphate buffer which was about 122.1 Cp. Swelling 
index of almond gum was measured using the same buffers. Swelling 
index of Gum almond was found to be low, and the lowest swelling index 
was observed in pH 7.4 phosphate buffer which was about 8.3% v/v.
In vitro drug release studies
In order to investigate the extent to which gum almond succeed in 
targeting the drug to the colon, ten formulations have been formulated 
and in vitro drug release studies have been conducted in the pH range, 
which normally accounted in the GIT. Further to mimic the colon 
environment, the colonic microflora was also taken into consideration 
for the in vitro release study, as polysaccharide polymers release 
the drug faster in the presence of colonic microflora as they release 
glycosidase. At the end of 2 hrs, the formulations without compression 
coat released 32.41%, 29.65 %, 22.93%, 19.03%, and 17.11%of the 
drug from F1, F2, F3, F4, and F5 gum almond formulations, respectively. 
Whereas, all the compression coated formulations (FC1, FC2, FC3, FC4, 
and FC5) released 0% drug during the same period. This indicates 
that compression coating with Eudragit S 100 succeeds in preventing 
the drug release in the stomach. This indicates that, almond Gum 
by increasing the concentration of polymer the drug release can be 
retarded. It was also observed that throughout release study; almond 
gum compression coated tablets containing a high concentration of 
polymer released the drug at slower pace.
Table 2: Flow properties of drug and polymers
Serial 
number
Parameter Diclofenac Almond 
gum
1 Bulk density (g/ml) 0.685 0.598
2 Tapped density (m/ml) 0.921 0.923
3 Carr’s index 33.13 35.21
4 Hausner’s ratio 1.27 1.54
5 Angle of repose 38° 41°
Table 3: Physical characterization of diclofenac sodium granules formulated with almond gum by wet granulation method










F1 21.5±0.33 0.275±0.012 0.321±0.016 1.143±0.052 11.89±0.25
F2 22.4±0.15 0.279±0.074 0.345±0.021 1.149±0.024 12.73±0.28
F3 21.3±0.18 0.283±0.015 0.322±0.021 1.175±0.031 12.75±0.27
F4 22.5±0.41 0.278±0.014 0.338±0.021 1.175±0.091 14.24±0.25
F5 22.3±0.11 0.255±0.016 0.311±0.012 1.144±0.004 15.19±0.28
FC1 23.3±0.43 0.216±0.019 0.346±0.013 1.243±0.006 16.87±0.54
FC2 21.2±0.12 0.277±0.014 0.313±0.011 1.223±0.026 16.0±0.09
FC3 21.6±0.18 0.285±0.014 0.326±0.022 1.245±0.023 17.15±0.67
FC4 23.2±0.23 0.267±0.014 0.321±0.014 1.167±0.031 18.92±0.09
FC5 23.6±0.28 0.279±0.019 0.353±0.012 1.158±0.038 19.58±0.09
SD: Standard deviation
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The present investigation has revealed that in spite of using the natural 
polymer alone, the hydrophilic nature of the polymer makes vulnerable 
to release the drug to some extent in the upper digestive tract. As a 
result, the use of the polymer alone may not successfully target the drug 
to the colon. Hence, there is a need of further coating of the tablet with 
pH-dependent enteric polymer.
Among all the formulations belonging to almond gum, FC5 containing 
70% of almond gum has shown the desired drug release profile. Hence, 
this formulation (70%) was selected to carry out the dissolution in the 
presence of rat cecal content.
When the drug release studies were carried out in the presence of rat 
cecal content, there was a significant increase in the drug release as 
compared to that of the release studies performed in the absence of rat 
cecal content. The rat cecal content in the release study was considered 
to mimic the human colonic environment as it contains microflora 
which releases many glycosidases and degrade the polysaccharide 
polymers.
Fig. 1: In vitro drug release testing using rat cecal contents under 
anaerobic conditions (with continuous CO2 supply, front view and 
top view)
Fig 2: Fourier transform infrared spectra of the pure drug
Fig. 3: Fourier transform infrared spectra of the pure almond gum
Table 5: Comparative dissolution profile of diclofenac sodium 















SGF (0.1 n HCl) 1 0 0 0 0 0




3 1.56 1.42 1.38 1.36 1.28
4 5.65 5.12 4.69 4.25 3.96
5 10.56 9.55 8.19 6.55 5.76
SCF (pH 6.8) 6 18.36 17.90 15.6 7.89 7.79
7 27.52 26.39 24.69 15.40 14.19
8 35.25 33.98 31.37 23.48 18.66
9 41.45 40.23 38.64 30.86 22.87
10 49.36 48.52 43.55 37.92 31.84
11 55.81 53.32 48.58 43.84 39.82
12 58.64 54.26 51.54 47.78 46.76
13 61.65 58.84 55.12 50.64 50.11
14 65.29 63.09 59.02 55.31 53.18
15 69.23 67.61 63.33 58.10 57.07
16 74.54 72.54 68.07 61.71 60.07
17 80.52 77.52 72.03 65.24 62.89
18 86.65 82.17 77.01 69.18 66.02
19 92.28 90.04 83.12 72.55 71.08
20 95.68 94.32 88.26 77.53 73.54
21 98.23 96.64 93.67 82.34 76.44
22 87.15 80.23
23 86.67
SGF: Simulated gastric fluid, SCF: Simulated colonic fluid
Table 6: Release kinetics for diclofenac sodium matrix tablets
Formulation Zero order (R2) First order (R2) T50 (hr) T90 (hr) Higuchi (R2) Peppas (R2) K (μg/hr) n
F1 0.980 0.968 8.98 15.17 0.893 0.905 5.56 0.598
F2 0.988 0.954 9.46 20.64 0.946 0.992 5.28 0.625
F3 0.990 0.977 11.36 22.86 0.943 0.978 3.48 1.175
F4 0.993 0.935 14.62 28.97 0.862 0.996 4.29 0.756
F5 0.996 0.980 16.77 30.20 0.965 0.997 4.98 0.254
FC1 0.996 0.912 11.46 17.69 0.938 0.987 4.36 1.026
FC2 0.991 0.973 15.43 21.77 0.842 0.993 3.24 1.236
FC3 0.996 0.921 18.91 29.61 0.872 0.994 3.87 1.021
FC4 0.997 0.978 19.16 31.08 0.924 0.978 2.48 1.642
FC5 0.995 0.959 21.06 34.11 0.933 0.917 3.68 1.365
Table 4: Physical properties of the diclofenac sodium matrix 









F1 501±0.7 99.23±0.18 7.2±0.02 0.39
F2 502±0.4 99.85±0.1 7.8±0.25 0.31
F3 499±0.6 101.39±0.21 7.9±0.34 0.35
F4 501±0.2 99.93±0.23 8.2±0.12 0.41
F5 498±0.5 101.88±0.39 8.8±0.06 0.39
FC1 702±0.8 100.16±0.51 8.2±0.58 0.32
FC2 701±0.3 99.64±0.63 8.5±0.40 0.38
FC3 699±0.1 101.24±0.17 8.6±0.24 0.35
FC4 698±0.6 101.16±0.39 8.8±0.45 0.28
FC5 702+0.9 100.18+0.69 8.9+0.67 0.19
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Fig 4: Fourier transform infrared spectra of combination of 


















In-vitro dissolution profile of formulation FC5 in presence and in 
absence of rat caecal contents
Series1
Series2
Fig. 5: Comparative dissolution profile of diclofenac sodium 
matrix tablets using almond gum (FC5) without cecal content and 
with cecal content
The drug release from Formulation FC5 was 0% in the first 2 hr. The 
drug release was negligible, i.e., it was only 9.83% at the end of 5hr. 
However, the release may be complete once the drug reaches the colon. 
Hence, a delayed action was observed. It was seen that Formulation FC5 
released 98.5% at the end of 23 hrs in the presence of rat cecal contents, 
whereas, formulation FC5 released 86.67% at the end of 22 hrs in the 
absence of rat cecal contents. This indicates that the drug release from 
the formulation is mainly due to the presence of enzymes released by 
micro-organisms of rat cecal contents (degradation). From this data, it 
can be concluded that almond gum can be used for targeting the drug 
to the colon. Further, if, they are coated with enteric polymer, efficiently 
can be targeted to the colon by avoiding the release in the upper 
intestinal part and the release of the drug are basically dependent upon 
the colon microflora degradation rather than any other factors.
In vivo targeting efficacy
To strengthen the in vitro release study finding, in vivo targeting 
efficiency study was carried out using formulation FC5. It is shown 
from the X-ray studies that the tablet remained in the stomach for the 
first 2 hrs (Fig. 6a) then it has reached the small intestine and remained 
intact for next 3 hrs (Fig. 6b). Then it has reached a large intestine and 
then reached colon and remained intact for 17 hrs (Fig. 6c) and finally 
tablet disintegrated in the 20 hr (Fig. 6d). It can be concluded from 
the X-ray images that the enteric coated tablets have remained intact 
in the upper part of the intestinal tract and swollen tablet picture in 
the colon indicates that the formulation releases the drug in the colon 
and hence, the colon specificity and the tablet remained intact without 
disintegration proving that the formulation is ideal for colon targeting.
From these results, almond gum can be successfully used for targeting 
the drug to the colon. The drug release from the polymer is dependent 
on the concentration of the polymer used, the more the concentration 
of the polymer the lesser is the drug release.
In all the formulations developed, the results were subjected to study 
the release kinetics. The values of the correlation coefficient indicated 
that the drug release followed zero order drug release kinetics with 
Peppas drug release mechanism. The values of T50% and T90% were 
found to be increased with increasing the proportion of polymers. The 
drug release mechanism was super case II transport as n>1.0.
CONCLUSION
The present work was aimed at developing colon targeted drug delivery 
of diclofenac sodium. A comparison study was done using various 
concentrations of almond gum in the preparation of matrix tablets of 
diclofenac sodium and matrix tablets are compression coated with 
Eudragit S100. Diclofenac sodium matrix tablets prepared with 70% 
(FC5) almond gum had slow drug release when compared with other 
formulations. The study shows that almond is able to target the drug to 
the colon. But it is dependent on the concentration of the polymer used. 
The release of the drug was more in the presence of cecal content than 
without the cecal content. The X-ray studies revealed that the formulated 
tablets are able to target the colon without getting disintegrated in the 
upper part of GIT. It was concluded that the compression coated matrix 
tablets of diclofenac sodium prepared by employing almond gum could 
be used for chronotherapy.
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